TOSK, INC.

ACTIVE

2672 Bayshore Pkwy Ste 507, Mountain View, California, United Stateswww.tosk.comPrivate11–50 employeesEstablished: 1998-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1998

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

84.6%

Phase 1

15.4%

Trial Status Distribution

Active, not recruiting

15.4%

Completed

69.2%

Recruiting

15.4%

Clinical Trials

Trials sponsored by this organization (13)

A clinical trial to study the Dose, Safety and tolerance of TK-112690 injection in Head and Neck cancer patients receiving radiation and chemotherapy

Phase 2

Recruiting

interventional

Jun 202330 participants

A clinical study to access safety and efficacy of TK-90 or parenteral TK-90 placebo in patients with colorectal cancer scheduled to receive bolus 5-fluorouracil and infused leucovorin.

Phase 2

Completed

interventional

Jul 202224 participants

A study to evaluate the safety and efficacy of test product TK-90 or placebo in Head and Neck cancer patients receiving radiotherapy.

Phase 2

Completed

interventional

Jun 202224 participants

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

Phase 2

Active, not recruiting

interventional

Jun 202224 participants

Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690

Phase 2

Active, not recruiting

interventional

Jun 202224 participants

A clinical trial to study the efficacy & Safety of IV of TK-112690 a new experimental drug to a placebo as a mucositis preventive in subjects with squamous cell cancer of Head & Neck scheduled to receive Methotrexate as chemotherapy

Phase 2

Completed

interventional

May 201922 participants

Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690

Phase 2

Completed

interventional

May 201922 participants

A Phase 1b, Multi-center, Study of New Drug METREXASSISTTM (Parenteral TK-112690) given with Methotrexate as a Weekly Infusion to Subjects with Head and Neck cancer patients Undergoing Treatment with Methotrexate. A Dose Increasing/Safety study with No Control

Phase 1

Completed

interventional

May 201725 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations